Cost-minimisation analysis of oral anticoagulant therapy monitoring methods: The case for prothrombin time self-monitoring

Hellenic Journal of Cardiology

Volumn 49, Issue 6, 2008, Pages 388-396

  Geitona, Mary ^a,b   Hollandezos, Mark ^b   Souliotis, Kyriakos ^c   Athanasakis, Kostas ^b   Kyriopoulos, John ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^c UNIVERSITY OF PELOPONNESE   (Greece)

Author keywords

Cost analysis; Cost minimisation; Oral anticoagulant therapy monitoring; Prothrombin time measurement method; Regulation by patient

Indexed keywords

ANTICOAGULANT AGENT; PROTHROMBIN;

ANTICOAGULANT THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DRUG MONITORING; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART VALVE REPLACEMENT; HUMAN; PROTHROMBIN TIME; SELF MONITORING;

ADMINISTRATION, ORAL; ANTICOAGULANTS; COST SAVINGS; GREECE; HUMANS; MONITORING, PHYSIOLOGIC; PROTHROMBIN TIME; SELF CARE; STATE MEDICINE;

EID: 57149102725     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gafou A. [Therapeutic management of thromboembolic disease]. Haema. 2001; Supplement 1: 44-57. Greek.
2. Ansell J, Hirsh J, Dalein J, et al. Managing oral anticoagulant therapy. Chest. 2001; 119: 228-388.
3. Guideline: Haemostasis and thrombosis task force for the British Committee for standards in haematology. Br J Haematol. 1998; 101: 374-387.
4. Fragakis N, Katsaris G. Arrhythmias in the elderly: modern management. Hellenic J Cardiol. 2006; 47: 84-92.
5. Ganotakis ES, Mikhailidis DP, Vardas PE. Atrial fibrillation, inflammation and statins. Hellenic J Cardiol. 2006; 47: 51-53.
6. Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy on vascular heart disease. J Thromb Thombolysis. 1998; 5: S.19.
7. Fitzmaurice DA, Machin SJ; British Society of Haematology Task Force for Haemostasis and Thrombosis. Recommendations for patients undertaking self management of oral anticoagulation. BMJ. 2001; 323: 985-989.
8. Ansell J, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring and patient self-management. Am Heart J. 1996; 132, 1095-1100.
9. Ansell JE. Empowering patients to monitor and manage oral anticoagulation therapy. JAMA. 1999; 281: 182-183.
10. Horstkotte O, Wiemer M, Schultheiss H. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy. Eur Heart J. 1996: 17S; 230.
11. Saour JN, Sieck JO, Mamo LA, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med. 1990; 322: 428-432.
12. Cortelazzo, Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost. 1993; 69: 316-320.
13. Ibrahim S, Kwoh K, Harper D, Baker D. Racial differences in the utilization of oral anticoagulant therapy in heart failure: A study of elderly hospitalized patients. J Gen Intern Med. 2000; 15: 134-137.
14. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995; 333: 11-17.
15. Bernardo A. [Self-monitoring of blood coagulation by patients. Principles, procedures and long-term outcome]. Med Monatsschr Pharm. 1997; 20: 30-35. German.
16. Heidinger K, Bernardo A, Taborski U, Muller-Berghaus G. Clinical outcome of self-management on oral anticoagulation in patients with arterial fibrillation or deep vein thrombosis. Thromb Res 2000; 98: 287-293.
17. Kortke H, Minami K, Breymann T, et al. [INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial)]. Z Kardiol. 2001; 90 (Suppl 6):118-24. German.
18. Anderson O, Harrison I, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long term oral anticoagulant therapy. Arch Intern Med. 1993; 153: 1441-1447.
19. White RH, McCurdy A, Marensdorff H, et al. Home prothrombin time monitoring after the initiation of warfarin therapy: a randomized, prospective study. Ann Intern Med. 1989; 111: 730-737.
20. Watzke H, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B. A prospective controlled trial comparing weekly self testing and self dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost. 2000: 83; 661-665.
21. Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S, Kyriopoulos I. Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study. Ann Gen Psychiatry [Internet]. 2008 [cited 2008 Aug 28]; 7: 16. Available from: http://www.annals-general-psychiatry.com/content/7/ 1/16
22. Beyth R, Quinn L, Landefeld C. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. Ann Intern Med. 2000; 133: 687-695.
23. Hasenkam J, Kimose H, Knudsen I, et al. Self management of oral anticoagulant therapy after heart valve replacement. Euro J Cardio Thor Surg. 1997; 11: 935-942.
24. Taborski U, Wittstamm F, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Sem Thromb Haemostasis. 1995; 25; 103-107.
25. Fitzmaurice DA. Oral anticoagulation control: the European perspective. J Thromb Thrombolysis. 2006; 21: 95-100.
26. Matchar DB, Samsa GP, Cohen SJ, Oddone EZ. Community impact of anticoagulation services: rationale and design of the managing anticoagulation services trial (MAST). J Thromb Thrombolysis. 2000; 9 (Suppl 1): S7-11.
27. Menendez-Jandula B, Souto JC, Oliver A, et al. Comparing self-management or oral anticoagulant therapy with clinic management: a randomized trial. Ann Int Med. 2005; 142: 1-10.
28. Henegan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006; 367: 404-411.
29. Campbell SM, Cantrill JA. Consensus methods in prescribing research. J. Clin Pharm Ther. 2001; 26: 5-14.
30. Allen J, Dyas J, Jones M. Building consensus in health care: a guide to using the nominal group technique. Br J Community Nurs. 2004; 9: 110-114.
31. Liaropoulos L, Spinthouri M, Ignatiades T, Ifandi G, Katostaras F, Diamantopoulos E. Economic evaluation of nimesulide vs diclofenac and the incidence of adverse events in the treatment of rheumatic disease in Greece. Pharmacoeconomics. 1998; 14: 575-588.
32. Sawicki P. A structured teaching and self-management program for patients receiving oral anticoagulation. JAMA. 1999; 281: 145-150.